glp-1-directed nmda receptor antagonism for obesity treatment Transforming obesity: The advancement of multi-receptor drugs: Cell GLP-1 Agonists for Obesity Treatment:

Glucose Control A clinically studied probiotic shown to nutritionally help lower post-meal blood sugar and A1C levels in people with type 2 diabetes.** Polyphenol Booster A targeted prebiotic that feeds and boosts Akkermansia muciniphila

Digestive issues

Moore also believes that slower, more sustainable weight loss allows the body more time to adjust to changes in weight, reducing the side-effect profile and potentially leading to better long-term success

Exendin-4 also promotes the polarization of bone marrow-derived macrophages in mice towards the M2 subtype by modulating the STAT3 pathway and cAMP protein kinase A (PKA) signaling [91, 92]

Notably, another important cell involved in the pathogenic process of RA is the fibroblast-like synoviocytes (FLSs), and there are more available studies that examine the effects of GLP-1RAs on FLSs